ARS Pharmaceuticals Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Tanimoto Sarina unloaded Company’s shares for reported $0.93 million on Apr 09 ’24. In the deal valued at $9.28 per share,100,000 shares were sold. As a result of this transaction, Tanimoto Sarina now holds 1,646,494 shares worth roughly $14.85 million.
Then, Lowenthal Richard E sold 100,000 shares, generating $927,735 in total proceeds. Upon selling the shares at $9.28, the PRESIDENT AND CEO now owns 1,646,494 shares.
Before that, RA CAPITAL MANAGEMENT, L.P. bought 505,954 shares. ARS Pharmaceuticals Inc shares valued at $4,953,290 were divested by the Director at a price of $9.79 per share. As a result of the transaction, RA CAPITAL MANAGEMENT, L.P. now holds 9,958,073 shares, worth roughly $89.82 million.
Leerink Partners upgraded its ARS Pharmaceuticals Inc [SPRY] rating to an Outperform from a a Market perform in a research note published on March 05, 2024; the price target was increased to $18 from $6. A number of analysts have revised their coverage, including William Blair’s analysts, who increased its forecast for the stock in mid February from “a Mkt perform” to “an Outperform”. William Blair also remained covering SPRY and has decreased its forecast on September 20, 2023 with a “Mkt perform” recommendation from previously “an Outperform” rating. Wedbush started covering the stock on January 31, 2023. It rated SPRY as “an Outperform”.
Price Performance Review of SPRY
On Friday, ARS Pharmaceuticals Inc [NASDAQ:SPRY] saw its stock fall -2.38% to $9.02. Over the last five days, the stock has lost -8.61%. ARS Pharmaceuticals Inc shares have risen nearly 64.60% since the year began. Nevertheless, the stocks have risen 51.34% over the past one year. While a 52-week high of $11.27 was reached on 03/28/24, a 52-week low of $2.55 was recorded on 01/04/24. SMA at 50 days reached $8.43, while 200 days put it at $6.29. A total of 0.69 million shares were traded, compared to the trading of 0.44 million shares in the previous session.
Levels Of Support And Resistance For SPRY Stock
The 24-hour chart illustrates a support level at 8.89, which if violated will result in even more drops to 8.75. On the upside, there is a resistance level at 9.20. A further resistance level may holdings at 9.37. The Relative Strength Index (RSI) on the 14-day chart is 49.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.37, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.21%. Stochastics %K at 21.69% indicates the stock is a holding.
The most recent change occurred on January 03, 2023 when William Blair began covering the stock and recommended ‘”an Outperform”‘ rating along with a $17 price target.
